Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: A randomized, placebo-controlled trial

Nutrition Journal

Volumn 12, Issue 1, 2013, Pages

  Lee, Bor Jen ^a   Tseng, Yu Fen ^b   Yen, Chi Hua ^b,c   Lin, Ping Ting ^b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antioxidation; Coenzyme Q10; Coronary artery disease; Inflammation; Statins

Indexed keywords

ADIPONECTIN; ALPHA TOCOPHEROL; C REACTIVE PROTEIN; CATALASE; CREATININE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXIDASE; PLACEBO; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE;

AGED; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG EFFECT; EXERCISE; FEMALE; HEART CATHETERIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CATALASE; CORONARY ARTERY DISEASE; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; OXIDATIVE STRESS; SINGLE-BLIND METHOD; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA; UBIQUINONE;

EID: 84887950110     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-12-142     Document Type: Article

References (37)

1. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. Braunwald E, N Engl J Med 1997 337 1360 1369 10.1056/NEJM199711063371906 9358131 (Pubitemid 27467771)
2. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? findings in 356,222 primary screenees of the multiple risk factor intervention trial (MRFIT). Stamler J, Wentworth D, Neaton JD, JAMA 1986 256 2823 2828 10.1001/jama.1986.03380200061022 3773199 (Pubitemid 17178359)
3. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK, Treating to New Targets (TNT) Investigators, N Engl J Med 2005 352 1425 1435 10.1056/NEJMoa050461 15755765 (Pubitemid 40471450)
4. Biochemical, physiological and medical aspects of ubiquinone function. Ernster L, Dallner G, Biochim Giophys Acta 1995 1271 195 204 10.1016/0925-4439(95)00028-3
5. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Bhagavan HN, Chopra RK, Free Radic Res 2006 40 445 453 10.1080/ 10715760600617843 16551570
6. Lovastatin decreases coenzyme Q10 levels in human. Folkers K, Langsjoen P, Willis R, Richardson P, Xia LJ, Ye CQ, Tamagawa H, Proc Natl Acad Sci U S A 1990 87 8931 8934 10.1073/pnas.87.22.8931 2247468 (Pubitemid 120007623)
7. Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study. Ghirlanda G, Oradei A, Manto A, Lippa S, Uccioli L, Caputo S, Greco AV, Littarru GR, J Clin Pharmacol 1993 33 26 29
8. Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients. Mabuchi H, Higashikata T, Kawashiri M, Katsuda S, Mizuno M, Nohara A, Inazu A, Koizumi A, Kobayashi A, J Atheroscler Thromb 2005 12 111 119 10.5551/jat.12.111 15942122
9. Effect of atorvastatin withdrawal on circulating coenzyme Q10 concentration in patients with hypercholesterolemia. Chu CS, Kou HS, Lee CJ, Lee KT, Chen SH, Voon WC, Sheu SH, Lai WT, Biofactors 2006 28 177 184 10.1002/biof.5520280304 17473378
10. Role of oxidative stress in atherosclerosis. Harrison D, Griendling KG, Landmesser U, Hornig B, Drexlar H, Am J Cardiol 2003 91 7 11 10.1016/S0002-9149(02)03144-2 (Pubitemid 36351457)
11. Inflammation, atherosclerosis, and psoriasis. Siegel D, Devaraj S, Mitra A, Raychaudhuri SP, Raychaudhuri SK, Jialal I, Clin Rev Allergy Immunol 2013 44 194 204 10.1007/s12016-012-8308-0 22359071
12. The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions. Alleva R, Tomasetti M, Battino M, Curatola G, Littarru GP, Folkers K, Proc Natl Acad Sci U S A 1995 26 9388 9391
13. Coenzyme Q10 supplementation and heart failure. Singh U, Devaraj S, Jialal I, Nutr Rev 2007 1 286 293 (Pubitemid 351804363)
14. The relationship between coenzyme Q10 and oxidative stress, antioxidant enzymes activities and coronary artery disease. Lee BJ, Lin YC, Huang YC, Ko YW, Hsia S, Lin PT, ScientificWorldJournal 2012 2012 792756 22645453
15. Coenzyme Q10 supplements reduce oxidative stress and increase activities of antioxidant enzymes in patients with coronary artery disease. Lee BJ, Huang YC, Chen SJ, Lin PT, Nutrition 2012 28 250 255 10.1016/j.nut.2011.06.004 21996047
16. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' health study. Ma J, Hennekens CH, Ridker PM, Stampfer MJ, J Am Coll Cardiol 1999 33 1347 1352 10.1016/S0735-1097(99)00007-8 10193737
17. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Ridker PM, Rifai N, Pfeifer M, Sacks F, Lepage S, Braunwald E, Circulation 2000 101 2149 2153 10.1161/01.CIR.101.18.2149 10801754 (Pubitemid 30253042)
18. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH, Circulation 2000 101 1767 1772 10.1161/01.CIR.101.15.1767 10769275 (Pubitemid 30213096)
19. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R, Circulation 2005 111 1448 1454 10.1161/01.CIR.0000158483. 13093.9D 15781756 (Pubitemid 40396812)
20. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, Kataoka T, Kamimori K, Shimodozono S, Kobayashi Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Heart 2004 90 528 533 10.1136/hrt.2003.011114 15084551 (Pubitemid 38530170)
21. Effects of coenzyme Q10 supplementation on inflammatory markers (high sensitivity C-reactive protein, interleukin-6 and homocysteine) in patients with coronary artery. Lee BJ, Huang YC, Chen SJ, Lin PT, Nutrition 2012 28 767 772 10.1016/j.nut.2011.11.008 22342390
22. HPLC method for simultaneous determination of retinol, alpha-tocopherol and coenzyme Q10 in human plasma. Karpińska J, Mikołuć B, Motkowski R, Piotrowska-Jastrzebska J, J Pharm Biomed Anal 2006 42 232 236 10.1016/j.jpba.2006.03.037 16765550 (Pubitemid 44279334)
23. Method to assay coenzyme Q10 in blood plasma or blood serum. Littarru GP, Mosca F, Fattorini D, Bompadre S, U S Pat 2007 7303921
24. Studies on the qualitative characterization of erythrocyte glutathione peroxidase. Paglia D, Valentine W, J Lab Clin Med 1967 70 159 169
25. Involvement of superoxide anion radical in autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Marklund S, Marklund G, Eur J Biochem 1974 47 469 474 10.1111/j.1432-1033.1974.tb03714.x 4215654
26. Catalase in vitro. Methods. Aebi H, Enzymol 1984 105 121 126
27. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP, Eur Heart J 2007 28 2249 2255 10.1093/eurheartj/ehm267 17644511 (Pubitemid 47428939)
28. Free radicals and antioxidants in cardiovascular health and disease. Bahorun T, Soobrattee MA, Luximon-Ramma V, Aruoma OI, Internet J Med Update 2006 1 25 41
29. Coenzyme Q10: is there a clinical role and a case for measurement? Molyneux SL, Young JM, Florkowski CM, Lever M, Georgr PM, Clin Biochem Rev 2008 29 71 82 18787645
30. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Stocker R, Bowry VW, Frei B, Proc Natl Acad Sci U S A 1991 88 1646 1650 10.1073/pnas.88.5.1646 2000375 (Pubitemid 21916282)
31. Interactions between ubiquinones and vitamins in membranes and cells. Constantinescu A, Maguire JJ, Packer L, Mol Aspects Med 1994 15 57 s65 7752845
32. Ubiquinone-dependent recycling of vitamin E radicals by superoxide. Stoyanovsky DA, Osipov AN, Quinn PJ, Kagan VE, Arch Biochem Biophys 1995 323 343 351 10.1006/abbi.1995.9955 7487097
33. Electron transport-linked ubiquinone-dependent recycling of tocopherol inhibits autooxidation of mitochondrial membranes. Lass A, Sohal RS, Arch Biochem Biophys 1998 352 229 236 10.1006/abbi.1997.0606 9587410 (Pubitemid 28368588)
34. Functions of coenzyme Q10 in inflammation and gene expression. Schmelzer C, Lindner I, Rimbach G, Niklowitz P, Menke T, Doring F, Biofactors 2008 32 179 183 10.1002/biof.5520320121 19096114
35. In vitro effects of the reduced form of coenzyme Q(10) on secretion levels of TNF-alpha and Chemokines in response to LPS in the human monocytic cell line THP-1. Schmelzer C, Lorenz G, Rinbach G, Doring F, J Clin Biochem Nutr 2009 44 62 66 10.3164/jcbn.08-182 19177190
36. Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes. Zhang YP, Eber A, Yuan Y, Yang Z, Rodriguez Y, Levitt RC, Takacs P, Candiotti KA, Anesthesiology 2013 118 945 954 10.1097/ALN.0b013e3182829b7b 23334664
37. Plasma adiponectin levels and risk of myocardial infarction in Men. Pischon T, Girman GJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB, JAMA 2004 291 1730 1737 10.1001/jama.291.14.1730 15082700 (Pubitemid 38489895)